Replies to post #80227 on Biotech Values

[DewDiligence]

Biolex taps Cook Pharmica to manufacture Locteron for phase-3 trials (and presumably for commercialization if the phase-3 trials are successful):

http://finance.yahoo.com/news/Biolex-Therapeutics-Selects-iw-3953994604.html?x=0&.v=1

Locteron is a long-acting interferon alpha for HCV derived from transgenic plants.